Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
2011 ◽
Vol 69
(1)
◽
pp. 221-227
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14019-14019
1981 ◽
Vol 21
(10)
◽
pp. 388-395
◽
2017 ◽
Vol 81
(2)
◽
pp. 419-419
◽